Your browser doesn't support javascript.
loading
A novel chiral oxazoline copper(II)-based complex inhibits ovarian cancer growth in vitro and in vivo by regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factors.
Fan, Rong; Wei, Jing-Chen; Xu, Bing-Bing; Jin, Nan; Gong, Xiao-Yi; Qin, Xiu-Ying.
Affiliation
  • Fan R; College of Pharmacy, Guilin Medical University, Guangxi, Guilin, 541004, China. xyqin6688@163.com.
  • Wei JC; College of Pharmacy, Guilin Medical University, Guangxi, Guilin, 541004, China. xyqin6688@163.com.
  • Xu BB; College of Pharmacy, Guilin Medical University, Guangxi, Guilin, 541004, China. xyqin6688@163.com.
  • Jin N; College of Pharmacy, Guilin Medical University, Guangxi, Guilin, 541004, China. xyqin6688@163.com.
  • Gong XY; College of Pharmacy, Guilin Medical University, Guangxi, Guilin, 541004, China. xyqin6688@163.com.
  • Qin XY; College of Pharmacy, Guilin Medical University, Guangxi, Guilin, 541004, China. xyqin6688@163.com.
Dalton Trans ; 52(33): 11427-11440, 2023 Aug 22.
Article in En | MEDLINE | ID: mdl-37539728
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Copper Limits: Animals / Female / Humans Language: En Journal: Dalton Trans Journal subject: QUIMICA Year: 2023 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Copper Limits: Animals / Female / Humans Language: En Journal: Dalton Trans Journal subject: QUIMICA Year: 2023 Type: Article Affiliation country: China